RP
Regeneron Pharmaceuticals Inc
🇺🇸XNAS.REGNUnited StatesHealthcare
$782.45USDdown -11.29 (-1.42%)OpenEnd of day2:25 PM
Price$782.45-11.29 (-1.42%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US75886F1075
- CUSIP
- 75886F107
Company
- Employees
- 15,410
- Headquarters
- Tarrytown, United States
- Website
- https://www.regeneron.com
- CEO
- Dr. Leonard S. Schleifer M.D., Ph.D.
Market
- Shares outstanding
- 101.1M
- Market cap
- $79.14B
Key dates
- Next earnings
- Oct 27, 2026
Highlights
- Market cap
- $79.14B
- EPS LTM
- $40.53
- P/E LTM
- 15.38
- Div yield
- 0.57%
Fundamentals (LTM)
- Revenue
- $15.53B+9.29%up year on year
- Net income
- $4.33B-2.91%down year on year
- Gross margin
- 84.86%-0.83%down year on year
- Free cash flow
- $3.52B-8.39%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.